06:31 AM EDT, 08/08/2024 (MT Newswires) -- Haemonetics ( HAE ) reported fiscal Q1 adjusted earnings Thursday of $1.02 per diluted share, down from $1.05 a year earlier.

Analysts polled by Capital IQ expected $1.01.

Net revenue for the quarter ended June 29 was $336.2 million, up from $311.3 million a year earlier.

Analysts surveyed by Capital IQ expected $335 million.

The company said it continues to expect fiscal 2025 adjusted earnings of $4.45 to $4.75 per diluted share. Analysts polled by Capital IQ expect $4.60.

Price: 86.00, Change: +0.28, Percent Change: +0.33